Curaxin MOA Animation for Roswell Park Cancer Institute
Animation demonstrates the mechanism of action of Curaxin molecules. Curaxins are candidate anticancer treatments developed by Cleveland Biolabs in collaboration with the Roswell Park Cancer Institute (RPCI). In 2016 RCPI invited Visual Science to create an animation on Curaxin technology as a part of a larger film about RPCI accomplishments in cancer research field.
Visualizing Curaxins’ mechanism of action was a complex task, because scientifically accurate animation of large macromolecular complexes with DNA and proteins requires large computing capacity. Curaxins are small molecules that have demonstrated the ability to kill a broad range of human tumor cells and sensitize tumor cells to other cancer treatments. Curaxins interfere with normal DNA packaging in the nuclei of the tumor cells, which triggers a number of changes in the biochemical cascades important for the tumor growth leading to destruction of the cancer cells.
More about the project: http://visual-science.com/projects/curaxin/animation
Contact Visual Science: mail@visual-science.com
Видео Curaxin MOA Animation for Roswell Park Cancer Institute канала Visual Science
Visualizing Curaxins’ mechanism of action was a complex task, because scientifically accurate animation of large macromolecular complexes with DNA and proteins requires large computing capacity. Curaxins are small molecules that have demonstrated the ability to kill a broad range of human tumor cells and sensitize tumor cells to other cancer treatments. Curaxins interfere with normal DNA packaging in the nuclei of the tumor cells, which triggers a number of changes in the biochemical cascades important for the tumor growth leading to destruction of the cancer cells.
More about the project: http://visual-science.com/projects/curaxin/animation
Contact Visual Science: mail@visual-science.com
Видео Curaxin MOA Animation for Roswell Park Cancer Institute канала Visual Science
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
CASE STUDY. Mechanism of Technology and Device Animations. Apton BiosystemsCASE STUDY. UNI-494 drug Mechanism of Action for Unicycive Therapeutics (NAS: UNCY)Scientific animation for drug-hunting platform. Scorpion Therapeutics3D animation-presentation typeMoA animation for Redpin Therapeutics' IR and corporate communication.MoA animation for Atsena Therapeutics' investor deck and websiteAtsena Therapeutics: Dual Vector animation. MoA animationNeoleukin NL-201 MoA animation. De novo protein development platformQuantitative Amplicon Sequencing (QASeq) NUPROBE 3D animation by Visual-SciencepH-Low Insertion Peptide Platform Technology for targeted deliveryHigh-end real-time AR application: Zika virus AR modeHigh-end real- time AR application: Rhinovirus AR modelHigh-end real-time AR application: Immunoglobulin GVisual Cortex Activation. 3D animation for holographic projection3D model of the SARS-CoV-2 virus at atomic resolutionIdentification of target DNA sequences by Lac repressor and CRISPR-Cas9 complexAnti-hypoxia Therapy — Mechanism of Action (MOA)Cybrexa Therapeutics Tumor Specific Drugs Mechanism of Action (MOA)Visual Science Short Medical Reel — Early 2017HIV Scientifically Accurate 3D Model